News from asieris A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.
Latest
Nov 11, 2020, 04:08 ET Asieris Announces First Patient Administration in the Global Phase III Clinical Trial for APL-1702
Asieris Pharmaceuticals, a China-based biotech company with global aspirations to discover, develop, and commercialize innovative drugs for the...
Nov 05, 2020, 00:59 ET Asieris Announces Approval of its Phase III Trial of a Novel Single Oral Agent as First-line Treatment for Non-Muscle Invasive Bladder Cancer (NMIBC)
Asieris Pharmaceuticals (Asieris), a China-based biotech company specializing in the development and commercialization of new drugs for the treatment ...
Oct 28, 2020, 21:17 ET Asieris' APL-1501 Approved for Phase I Clinical Trial in Australia
Asieris Pharmaceuticals, a China-based biotech company specializing in the development and commercialization of new drugs for the treatment of...
Jul 08, 2020, 10:00 ET Asieris Received China NMPA's Approval to Start a Global Phase III Clinical Trial for APL-1702 to Treat Cervical Precancerous Lesions (HSIL)
Asieris Pharmaceuticals (Asieris), a China-based biotech company with global aspirations to discover, develop and commercialize innovative drugs for...
Dec 19, 2019, 09:00 ET Asieris Wins Questex's Fierce Innovation Awards - Life Sciences Edition 2019
Asieris, a China-based biotech company specializing in the development and commercialization of new drugs for the treatment of genitourinary tumors...
Jul 02, 2019, 09:40 ET Asieris and Photocure Enter into a License Agreement for World-Wide Development and Commercialization of Cevira®
Asieris MediTech Co, Ltd (Asieris), a China-based biotech company specializing in the development and commercialization of new drugs for the...
Jun 24, 2019, 09:40 ET Asieris Announces Completion of Enrollment for its US APL-1202 Phase Ib Clinical Trial
Asieris, a China-based biotech company specializing in the development and commercialization of new drugs for the treatment of genitourinary tumors...
